Allocations
Vesttoo, a global Alternative Reinsurance and Investment platform, has secured a USD15 million Series B equity investment from Mouro Capital, which is backed by a large multinational bank, and MS&AD Ventures, the corporate venture capital fund of Japan-based MS&AD Insurance Group Holdings, the fifth largest insurance conglomerate in the world.
MarkLogic Corporation, a specialist in complex data integration and a portfolio company of Vector Capital, has acquired Smartlogic, a metadata management solutions provider and specialist in semantic AI technology.
As part of the transaction, Smartlogic’s founder and Chief Executive Officer, Jeremy Bentley, as well as other members of the senior management team, will join the MarkLogic executive team. Financial terms of the transaction were not disclosed.
Founded in 2006, Smartlogic has deciphered, filtered, and connected data for many of the world’s largest organizations to help solve their complex data problems. Global organisations in the energy, healthcare, life sciences, financial
Luma Health, a patient engagement platform, has raised USD130 million in a Series C funding round led by FTV Capital, a sector-focused growth equity investment firm, with participation from existing investors.
This latest round brings Luma Health’s total funding raised to USD160 million.
The announcement follows 2x growth year over year since Luma Health’s founding in 2015 and nearly 900 per cent three-year growth, garnering recognition as one of the Inc. 5000 Fastest-Growing Private Companies. Luma Health is on track to connect nearly a quarter of all Americans to care in 2022 and scale internationally.
“In the tight-knit community
Chloe Capital and Cornell University are helping climate tech innovators launch and advance solutions to the world’s climate crisis.
During the recent Diversity In ClimateTech business accelerator, five women-led climate tech companies were selected, based on their potential impact, to pitch and secure business deals.
The accelerator, which convened in Ithaca, NY, was designed to connect the women entrepreneurs with investors. Over USD500,000 in investments were offered by Chloe Capital to select underrepresented female founders who are projected to be leaders in the growing sustainable and clean technology industries.
“Something interesting we noticed when we were screening applicants for this
Innovative digital payments company, Pomelo Pay (Pomelo) has raised USD10 million in a Series A round led by UK-based independent investment firm Inference Partners.
The investment will allow the company to expand its presence across global markets including Europe and Asia, starting with plans to double their workforce in London, Singapore, Vietnam, Thailand and the Philippines.
Launched in 2018 in the UK and Singapore, Pomelo allows merchants to digitise their payment infrastructure and take payments from anyone, in any location (physical or digital), at near zero costs. The company provides an integration with over 30 payment networks globally. Its payments
Lower-mid market private equity firm NorthEdge is celebrating a year of success with pure-play e-commerce brand, Lights4fun.
NorthEdge announced its investment into the direct-to-consumer business in November 2020 and has since achieved many key milestones with the brand.
Within the first twelve months of the partnership, NorthEdge has supported the management team at Lights4fun to make several key hires which help unlock the significant growth potential, both in the UK and internationally.
David Stern was appointed as the business’ first Chair, followed by Amman Boughan as CFO and Ikonya Nginyo, who was appointed to lead the
Arlington Capital Partners (Arlington) portfolio company, BlueHalo, a provider of advanced engineering solutions and technology to the national security community, has acquired Asymmetrik.
Founded in 2008, Asymmetrik is a leading developer of software solutions and technology tools used to enable the Intelligence Community’s (IC) most advanced programs. With a strong presence in Ft. Meade, MD and Northern Virginia, Asymmetrik delivers leading Open Source Intelligence (OSINT) technologies to enable the collection and analysis of Publicly Available Information (PAI). The company has extensive experience developing applications across multiple domains including OSINT, AI/ML, cryptocurrency, block chain analytics, real-time streaming analytics, cybersecurity, and federated
Caixa Capital Risc, the venture capital subsidiary of CriteriaCaixa, has sold its portfolio company Sanifit Therapeutics to Vifor Pharma, a global pharmaceutical company that aims to become an industry leader in iron deficiency, nephrology and cardio-renal therapies.
Under the terms of the agreement, Vifor Pharma will acquire 100 per cent of the outstanding shares in Sanifit; receiving full global rights for its lead compound, SNF472. Shareholders of Sanifit will receive an upfront payment of EUR205 million (USD231 million), clinical, regulatory and market access milestones for up to EUR170 million (USD192 million) and tiered sales-based milestones that could reach mid to
Funds managed by Apollo affiliates have agreed to acquire a 50 per cent stake in Broad Reach Power LLC (Broad Reach), a leading utility-scale energy storage and renewable energy platform in the US.
The Apollo Funds will acquire the stake from existing investor EnCap Investments LP (EnCap) and its co-investment partners Yorktown Partners and Mercuria Energy. EnCap and its co-investment partners will retain the other 50 per cent stake and, together with the Apollo Funds, commit to invest up to USD400 million of additional equity to fund Broad Reach’s continued expansion and growth pipeline.
Broad Reach is a leading
LoQus23 Therapeutics (LoQus23), a company discovering small molecule therapies that target aberrant DNA mismatch repair (MMR) to treat Huntington’s and other triplet repeat diseases (TRDs), has closed its GBP7 million extended seed round.
LoQus23 secured the financing from Novartis Venture Fund (NVF) and its founding investor the Dementia Discovery Fund (DDF). This round follows an initial GBP4.5 million seed investment by the DDF in 2019.
Triplet repeat diseases are genetic disorders that primarily affect the nervous system and are caused by abnormal trinucleotide repeat expansions. Human genome-wide association studies on Huntington’s disease and other TRDs has shown clearly
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
